Plumbline Life Sciences, Inc. (XKON:222670)
South Korea
· Delayed Price · Currency is KRW
5,170.00
-270.00 (-4.96%)
At close: Dec 4, 2025
Plumbline Life Sciences Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| FY 2014 |
| Dec '14 Dec 31, 2014 |
| Net Income | -773.99 |
| Depreciation & Amortization | 241.78 |
| Other Operating Activities | 193.82 |
| Change in Other Net Operating Assets | 2.29 |
| Operating Cash Flow | -336.1 |
| Capital Expenditures | -2.5 |
| Investing Cash Flow | -2.5 |
| Issuance of Common Stock | 774.22 |
| Financing Cash Flow | 774.22 |
| Net Cash Flow | 435.61 |
| Free Cash Flow | -338.61 |
| Free Cash Flow Per Share | -337.30 |
| Change in Working Capital | 2.29 |
Source: S&P Capital IQ. Standard template.
Financial Sources.